Minimal disease detection and confirmation in hematologic malignancies: Combining cell sorting with clonality profiling

Clinical Chemistry

Volumn 52, Issue 3, 2006, Pages 430-437

  Zehentner, Barbara K ^a   Fritschle, Wayne ^a   Stelzer, Tess ^a   Ghirardelli, Keely M ^a   Hunter, Kimberly ^a   Wentzel, Collette ^a   Bennington, Richard ^a   Hansen, Christian L ^c   Myerson, David ^b   Kalnoski, Michael ^a   Wells, Denise A ^a   Loken, Michael R ^a  

^a HEMATOLOGICS INC   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Montage Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPLICON; ARTICLE; BONE MARROW BIOPSY; CAPILLARY ELECTROPHORESIS; CELL SELECTION; CLONAL VARIATION; FLOW CYTOMETRY; FLUORESCENCE; GENE REARRANGEMENT; GENOTYPE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOMA; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS;

ADULT; B-LYMPHOCYTES; FEASIBILITY STUDIES; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT; GENOTYPE; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA, B-CELL, ACUTE; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TUMOR STEM CELLS;

EID: 33644518989     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.061259     Document Type: Article

References (39)

1. Szczepanski T, Orfao A, van der Velden VH, San Miguel JF, van Dongen JJ. Minimal residual disease in leukaemia patients. Lancet Oncol 2001;2:409-17.
2. van Dongen JJ, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L, et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998;352:1731-8.
3. Bruggemann M, Pott C, Ritgen M, Kneba M. Significance of minimal residual disease in lymphoid malignancies. Acta Haematol 2004;112:111-9.
4. Cave H, van der Werfften Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group. N Engl J Med 1998;339:591-8.
5. Coustan-Smith E, Sancho J, Hancock ML, Boyett JM, Behm FG, Raimondi SC, et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 2000;96:2691-6.
6. Coustan-Smith E, Sancho J, Behm FG, Hancock ML, Razzouk BI, Ribeiro RC, et al. Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia. Blood 2002;100:52-8.
7. Wells DA, Sale GE, Shulman HM, Myerson D, Bryant EM, Gooley T, et al. Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation. Am J Clin Pathol 1998;110:84-94.
8. Radich J, Ladne P, Gooley T. Polymerase chain reaction-based detection of minimal residual disease in acute lymphoblastic leukemia predicts relapse after allogeneic BMT. Biol Blood Marrow Transplant 1995;1:24-31.
9. Bahloul M, Asnafi V, Macintyre E. Clinical impact of molecular diagnostics in low-grade lymphoma. Best Pract Res Clin Haematol 2005;18:97-111.
10. Hoshino A, Funato T, Munakata Y, Ishii T, Abe S, Ishizawa K, et al. Detection of clone-specific immunoglobulin heavy-chain genes in the bone marrow of B-cell-lineage lymphoma after treatment. Tohoku J Exp Med 2004;203:155-64.
11. Ciudad J, San Miguel JF, Lopez-Berges MC, Garcia Marcos MA, Gonzalez M, Vazquez L, et al. Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL. Br J Haematol 1999;104:695-705.
12. Lucio P, Parreira A, van den Beemd MW, van Lochem EG, van Wering ER, Baars E, et al. Flow cytometric analysis of normal B-cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia 1999;13:419-27.
13. Bradfield SM, Radich JP, Loken MR. Graft-versus-leukemia effect in acute lymphoblastic leukemia: the importance of tumor burden and early detection. Leukemia 2004;18:1156-8.
14. Wells DA, Benesch M, Loken MR, Vallejo C, Myerson D, Leisenring WM, et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 2003;102:394-403.
15. van der Velden VH, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, van Dongen JJ. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 2003;17:1013-34.
16. van der Velden VH, Wijkhuijs JM, Jacobs DC, van Wering ER, van Dongen JJ. T cell receptor γ gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis. Leukemia 2002;16:1372-80.
17. van der Velden VH, Willemse MJ, van der School CE, Hahlen K, van Wering ER, van Dongen JJ. Immunoglobulin κ deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR. Leukemia 2002;16:928-36.
18. Beishuizen A, Verhoeven MA, van Wering ER, Hahlen K, Hooijkaas H, van Dongen JJ. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis. Blood 1994;83:2238-47.
19. Kerst G, Kreyenberg H, Roth C, Well C, Dietz K, Coustan-Smith E, et al. Concurrent detection of minimal residual disease in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR. Br J Haematol 2005;128:774-82.
20. Campana D. Minimal residual disease studies in acute leukemia. Am J Clin Pathol 2004;122(Suppl):S47-57.
21. Bottchers, Ritgen M, Pott C, Bruggemann M, Raff T, Stilgenbauer S, et al. Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation. Leukemia 2004;18:1637-45.
22. Malec M, van der Velden VH, Bjorklund E, Wijkhuijs JM, Soderhall S, Mazur J, et al. Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping. Leukemia 2004;18:1630-6.
23. Sausville JE, Salloum RG, Sorbara L, Kingma DW, Raffeld M, Kreitman RJ, et al. Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy-chain gene. Am J Clin Pathol 2003;119:213-7.
24. Wells DA, Hall MC, Shulman HM, Loken MR. Occult B-cell malignancies can be detected by three-color flow cytometry in patients with cytopenias. Leukemia 1998;12:2015-23.
25. Stelzer GT, Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann N Y Acad Sci 1993;677:265-80.
26. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-317.
27. Loken MR, Wells DA. Normal antigen expression in hematopoiesis: basis for interpreting leukemia phenotypes. In: Stewart C, Nicholson J, eds. Immunophenotyping. New York: Wiley Liss, 2000:133-60.
28. Sievers, EL, Lang BJ, Buckley JD, Smith FO, Wells DA, Daigneault-Creech CA, et al. Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry. J Nat Can Inst 1996;88:1483-8.
29. Pongers-Willemse MJ, Verhagen OJ, Tibbe GJ, Wijkhuijs AJ, de Haas V, Roovers E, et al. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region-specific TaqMan probes. Leukemia 1998;12:2006-14.
30. Bruggemann M, Droese J, Bolz I, Luth P, Pott C, von Neuhoff N, et al. Improved assessment of minimal residual disease in B-cell malignancies using fluorogenic consensus probes for real-time quantitative PCR. Leukemia 2000;14:1419-25.
31. Donovan JW, Ladetto M, Zou G, Neuberg D, Poor C, Bowers D, et al. Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia. Blood 2000;95:2651-8.
32. Sood R, Stewart CC, Aplan PD, Murai H, Ward P, Barcos M, et al. Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood 1998;91:3372-8.
33. van Wering ER, van der Linden-Schrever BE, van der Velden VH, Szczepanski T, van Dongen JJ. T-Lymphocytes in bone marrow samples of children with acute lymphoblastic leukemia during and after chemotherapy might hamper PCR-based minimal residual disease studies. Leukemia 2001;15:1301-3.
34. Szczepanski T, van der Velden VH, Raff T, Jacobs DC, van Wering ER, Bruggemann M, et al. Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALL. Leukemia 2003;17:2149-56.
35. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy". J Exp Med 1994;179:609-18.
36. Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran TP Jr. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997;89:256-60.
37. Lacy MQ, Kurtin PJ, Tefferi A. Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood 1996;87:3000-6.
38. Delabesse E, Burtin ML, Millien C, Madonik A, Arnulf B, Beldjord K, et al. Rapid multifluorescent TCRG Vγ and Jγ typing: application to T-cell acute lymphoblastic leukemia and to the detection of minor clonal populations. Leukemia 2000;14:1143-52.
39. Hodges E, Krishna MT, Pickard C, Smith JL. Diagnostic role of tests for T-cell receptor genes. J Clin Pathol 2003;56:1-11.